See more : Bank of Queensland Limited (BKQNF) Income Statement Analysis – Financial Results
Complete financial analysis of Applied Biosciences Corp. (APPB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Applied Biosciences Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- New Generation Consumer Group, Inc. (NGCG) Income Statement Analysis – Financial Results
- PT Segar Kumala Indonesia Tbk (BUAH.JK) Income Statement Analysis – Financial Results
- Sabuy Technology Public Company Limited (SABUY.BK) Income Statement Analysis – Financial Results
- SPK Acquisition Corp. (SPKAU) Income Statement Analysis – Financial Results
- Idsud S.A. (ALIDS.PA) Income Statement Analysis – Financial Results
Applied Biosciences Corp. (APPB)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.appliedbiocorp.com
About Applied Biosciences Corp.
Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 88.67K | 723.35K | 707.06K | 197.55K | 45.55K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 406.55K | 436.55K | 521.77K | 155.55K | 6.39K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -317.88K | 286.80K | 185.29K | 42.01K | 39.16K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -358.52% | 39.65% | 26.21% | 21.26% | 85.97% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 2.09M | 953.48K | 141.86K | 98.11K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 698.19K | 356.95K | 16.90K | -69.67K | 0.00 | 0.00 |
| SG&A | 374.87K | 3.38M | 2.79M | 1.31M | 158.76K | 28.45K | 16.67K | 1.82K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 374.87K | 3.38M | 2.83M | 1.54M | 178.72K | 28.45K | 16.67K | 1.82K |
| Cost & Expenses | 781.42K | 3.81M | 3.35M | 1.69M | 185.11K | 28.45K | 16.67K | 1.82K |
| Interest Income | 873.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 1.01M | 648.88K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 174.49K | 204.04K | 40.63K | 224.77K | 19.96K | 98.11K | 0.00 | 0.00 |
| EBITDA | -725.18K | -3.75M | -1.99M | -2.16M | -119.60K | 0.00 | -16.67K | -1.82K |
| EBITDA Ratio | -817.88% | -518.85% | -368.52% | -189.70% | 563.66% | 0.00% | 0.00% | 0.00% |
| Operating Income | -692.76K | -3.09M | -2.65M | -599.53K | -515.92K | -28.45K | -16.67K | -1.82K |
| Operating Income Ratio | -781.32% | -427.13% | -374.27% | -303.48% | -1,132.55% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -206.91K | -1.88M | -32.72K | -155.55K | -396.32K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -899.67K | -4.97M | -2.68M | -2.39M | -515.92K | -28.45K | -16.67K | -1.82K |
| Income Before Tax Ratio | -1,014.68% | -686.49% | -378.89% | -1,208.21% | -1,132.55% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -339.36K | -1.16M | 599.18K | 882.90K | 378.10K | -98.11K | 0.00 | 0.00 |
| Net Income | -767.22K | -4.67M | -2.63M | -2.38M | -517.66K | -28.45K | -16.67K | -1.82K |
| Net Income Ratio | -865.30% | -646.10% | -371.87% | -1,202.76% | -1,136.36% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.34 | -0.22 | -0.16 | -0.04 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.04 | -0.34 | -0.22 | -0.16 | -0.04 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 19.43M | 13.71M | 11.91M | 15.07M | 12.05M | 25.90M | 259.00M | 212.51M |
| Weighted Avg Shares Out (Dil) | 19.43M | 13.71M | 11.91M | 15.07M | 12.05M | 25.90M | 259.00M | 212.51M |
Source: https://incomestatements.info
Category: Stock Reports